Search Results 1-10 of 16649 for intestinal metaplasia

  1. Gastrointestinal Neoplasia Clinic - Overview

    Gastrointestinal stromal tumors (GISTs); Gastric intestinal metaplasia; Lymphoma of colon or rectum; Melanoma of the GI tract; Uncommon neoplasms of the stomach ...

  2. Assessing the timeline, location and patterns of recurrence in patients achieving complete remission after radiofrequency ablation - Mayo Clinic

    Treatment with RFA and resection can reduce the risk of cancer progression and induce complete remission of intestinal metaplasia (CRIM), both endoscopically ...

  3. Mayo Clinic Q and A: Determining foods to avoid when managing Barrett's esophagus

    That means the normal cells of the esophagus, called “squamous cells,” are replaced by intestinal cells. “Metaplasia” means the replacement of one cell by ...

  4. Barrett's esophagus - Symptoms and causes - Mayo Clinic

    Between the esophagus and the stomach is a critically important valve, the lower esophageal sphincter (LES). Over time, the LES may begin to fail, leading to ...

  5. Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus with Radiofrequency Ablation - Mayo Clinic

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

  6. A Study to Evaluate Bile Acid Reflux in Patients with Recurrent Barrett’s Esophagus - Mayo Clinic

    ... intestinal metaplasia, dysplasia, or EAC versus patients who achieved complete remission for at least > 1 year following initial endoscopic intervention ...

  7. Assessing the prevalence of Barrett's esophagus in patients with scleroderma - Mayo Clinic

    ... intestinal metaplasia. BE , which can progress to dysplasia, is a known risk factor for esophageal adenocarcinoma. A handful of older, smaller studies ...

  8. Barrett's Esophagus Clinical Trials - Mayo Clinic Research

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

  9. Barrett's Esophagus Clinical Trials

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

  10. Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation? - Mayo Clinic

    ... intestinal metaplasia following endoscopic ablation. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...